IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$310M
AUM Growth
+$8.93M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$13.4M
2
+$7.82M
3
+$6.27M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.06M
5
XLRN
Acceleron Pharma
XLRN
+$5.28M

Top Sells

1
+$20.1M
2
+$9.04M
3
+$6.17M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$2.33M

Sector Composition

1 Healthcare 98.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$353K 0.11%
9,500
52
$210K 0.07%
5,653
53
$148K 0.05%
10,000
54
– –
-37,600
55
– –
-27,000
56
– –
-23,100
57
– –
-236,832
58
– –
-46,500
1 2
3